Ladeana Smedlund, APRN
Family · Boys Town, NENPI 1871071019
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 67.6% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $11,997 and has fallen 99.8% since, to $25 in 2025. Among family clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 399 payments — averaging $51.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$14K
- Harmony Biosciences LLC$1K
- AstraZeneca$987
- Inspire Medical Systems, Inc.$574
- GSK$484
- Mallinckrodt Hospital Products Inc.$418
- plus $3K from 19 others
What the payments were for
- Consulting fees$1501%
- Speaking & faculty fees$8,82043%
- Travel & lodging$4,03120%
- Food & beverage$6,91834%
- Education$6273%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 65 | $13,895 |
| Harmony Biosciences LLC | 90 | $1,389 |
| AstraZeneca | 39 | $987 |
| Inspire Medical Systems, Inc. | 8 | $574 |
| GSK | 44 | $484 |
| Mallinckrodt Hospital Products Inc. | 12 | $418 |
| Regeneron Healthcare Solutions, Inc. | 22 | $326 |
| Boehringer Ingelheim | 16 | $301 |
| Axsome Therapeutics, Inc. | 15 | $282 |
| Grifols USA, LLC | 11 | $236 |
| Amgen | 11 | $220 |
| Pulmonx Corporation | 2 | $217 |
| Astellas Pharma US Inc | 4 | $208 |
| Avadel CNS Pharmaceuticals, LLC | 12 | $189 |
| United Therapeutics Corporation | 9 | $186 |
| Electromed, Inc. | 16 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Idorsia Pharmaceuticals US Inc | 6 | $91 |
| Mylan Specialty L.p. | 4 | $63 |
| Sanofi | 3 | $48 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Insmed, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,546 in reported general payments places this provider in the 95th percentile of 809 family providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 15 | $294,519 |
| WakixPitolisant Hcl | 20 | $233,517 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 108 | $73,556 |
| TezspireTezepelumab-Ekko | 13 | $57,414 |
| Breo ElliptaFluticasone/Vilanterol | 90 | $41,671 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $22,273 |
| SunosiSolriamfetol Hcl | 14 | $12,131 |
| Wellbutrin SrBupropion Hcl | 11 | $9,706 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 19 | $9,573 |
| DuleraMometasone/Formoterol | 19 | $6,903 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $4,446 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $3,007 |
| Armodafinil | 17 | $1,545 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 66 | $1,455 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $1,328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $1,389 | $233,51720 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $484 | $124,800217 claims |
| AstraZenecaTezspire, Breztri Aerosphere | $987 | $79,68743 claims |
| Axsome Therapeutics, Inc.Sunosi | $282 | $12,13114 claims |
| MerckDulera | $14 | $6,90319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 809 family providers in Nebraska.
Other family in Boys Town
- Chantel CollierFriend$257K
- Stephanie SimonOmaha$157K
- Rebecca NewberryOmaha$156K
- Michelle BrtekzwienerNorfolk$59K
- Angela CraigOmaha$35K
- Laura FalconeOmaha$26K
- Brittany MatneyOmaha$14K
- Patricia TeeterWahoo$13K
- Mary MetzLincoln$13K
- Sara LegleiterOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.